SecBot SecBot
DEFA14A ·Filed May 13, 2026

MCHX

MARCHEX INC
MIXED
Impact 6/10
Horizonweeks Processed5mo ago SEC0001193125-26-221700
Proxy solicitation materials
Actionable Insight ◆ Mixed

The Q1 revenue decline is a clear negative, but the raised Q2 EBITDA guidance and Archenia acquisition narrative provide a potential catalyst. Traders should watch for the proxy statement filing and stockholder vote on the Archenia deal, as well as Q2 results to see if sequential revenue growth materializes. The stock's small cap and low liquidity amplify moves on binary outcomes.

DirectionMixed
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
MCHX ▲ +10.49% at T+60d
NEUTRAL call +10.49% · α vs SPY +6.90% · entry $1.62 → $1.79
Entry = T+0 close
May 13, 2026
via day close
T+1d
0.00%
call 0.00% · α +1.23%
$1.62
settled 6mo ago
T+5d
+3.09%
call +3.09% · α +3.80%
$1.67
settled 5mo ago
T+20d
-4.32%
call -4.32% · α -3.46%
$1.55
settled 5mo ago
T+60d
+10.49%
call +10.49% · α +6.90%
$1.79
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Marchex reported Q1 2026 revenue of $10.6M (down 7% YoY from $11.4M) and a net loss of $1.7M, improved from a $2.0M loss a year ago. The company provided upbeat forward guidance for Q2 and Q3 2026, raised its Q2 Adjusted EBITDA guidance to $1.6–$1.8M, and updated progress on its planned acquisition of Archenia, which requires disinterested stockholder approval and is expected to close in July 2026.

Key Financial Metrics

Vote
merger approval

Key Facts

  • Q1 2026 GAAP revenue $10.6M vs $11.4M in Q1 2025 (YoY decline of ~7%)
  • Q1 2026 net loss $1.7M ($0.04/diluted share) vs $2.0M loss ($0.05/share) in Q1 2025
  • Q1 2026 Adjusted EBITDA loss of $0.1M, improving from a $0.8M loss in Q1 2025; excluding $0.7M reorganization/acquisition costs, Adjusted EBITDA gain would be $0.6M
  • Q2 2026 Adjusted EBITDA guidance raised to $1.6–$1.8M (from prior >$1M); revenue expected to increase sequentially
  • Q3 2026 stand-alone Adjusted EBITDA guidance ~$2M; combined with Archenia potentially ~$2.5M or more
  • Marchex entered into a Stock Purchase Agreement on May 8, 2026 to acquire 100% of Archenia; transaction requires disinterested stockholder approval, expected to close in July 2026
  • Special Committee of independent directors approved the SPA; Craig-Hallum provided fairness opinion; DLA Piper served as independent legal counsel
  • Combined company revenue run rate estimated at ~$15M quarterly (~$60M annualized) with potential 15–20% growth in 2026 (forward-looking, not historical)
  • Cash and cash equivalents $9.0M at March 31, 2026 vs $9.9M at December 31, 2025

Financial Impact

Q1 2026 revenue declined ~$0.8M YoY (7%); net loss improved by ~$0.3M. Forward guidance implies sequential revenue growth and Adjusted EBITDA improvement to $1.6–$1.8M in Q2 2026. The Archenia acquisition could add ~$15M quarterly revenue run rate if closed.

revenuenet lossadjusted EBITDAcash and cash equivalents

Risk Factors

  • Archenia acquisition requires disinterested stockholder approval and may not close
  • Revenue declined YoY for Q1 2026; forward guidance is aspirational and not guaranteed
  • Cash burn continues; cash decreased ~$0.9M from year-end 2025
  • Related-party transaction structure introduces governance risk
  • Low market cap ($70M) and limited analyst coverage increase volatility

Market Snapshot

Exchange
Nasdaq
Sector
Services-Prepackaged Software
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Software & IT

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001193125-26-221700
Document: defa14a_-_q1_2026_earnin.htm0001193125-26-221700
Document: 0001193125-26-221700-index-headers.html0001193125-26-221700
Document: 0001193125-26-221700-index.html0001193125-26-221700
Document: 0001193125-26-221700.txt0001193125-26-221700
8 reports for MCHX
Performance horizon
Filters
Rows
Reports for MCHX — sortable, filterable
TypeNow
Sep 22, 2026
4w ago
Press Release
NEUTRAL ★ 2/10
$1.42 $1.28▼ −9.86%▼ −9.30%$1.26 (−11.27%)
Aug 12, 2026
10w ago
8-K
MIXED ★ 6/10
$1.82 $1.37▼ −25.00%▼ −23.25%$1.26 (−30.77%)
Jun 5, 2026
20w ago
DEFM14A
NEUTRAL ★ 5/10
$1.53 $1.76▲ +15.03%▲ +13.40%$1.26 (−17.65%)
May 26, 2026
21w ago
PREM14A
MIXED ★ 5/10
$1.63 $1.50▼ −7.98%▼ −6.07%$1.26 (−22.70%)
May 13, 2026
23w ago
8-K
MIXED ★ 6/10
$1.62 $1.55▼ −4.32%▼ −3.46%$1.26 (−22.22%)
May 13, 2026
23w ago
DEFA14A
MIXED ★ 6/10
$1.62 $1.55▼ −4.32%▼ −3.46%$1.26 (−22.22%)
May 1, 2026
25w ago
8-K
NEUTRAL ★ 2/10
$1.73 $1.67▼ −3.47%▼ −9.11%$1.26 (−27.17%)
Apr 17, 2026
27w ago
10-K/A
NEUTRAL ★ 2/10
$1.72 $1.66▼ −3.49%▼ −7.69%$1.26 (−26.74%)
Showing 8 of 8

US Market Status

Market Closed — Opens in 2h 28m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 13, 2026